Cite

HARVARD Citation

    Vizzardi, E. et al. (n.d.). A New Antiarrhythmic Drug in the Treatment of Recent‐Onset Atrial Fibrillation: Vernakalant. Cardiovascular therapeutics. 31 (5), pp. e55-e62. [Online]. 
  
Back to record